Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZTS Zoetis Inc.

盘前交易 07-31 07:35:16 EDT

76.03

-1.90

-2.44%

盘前76.43

+0.40+0.53%

07:32 EDT

最高77.38	最低75.26	成交量477.86万
今开77.00	昨收77.93	日振幅2.72%
总市值318.74亿	流通市值318.74亿	总股本4.19亿
成交额3.63亿	换手率1.14%	流通股本4.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZTS","market":"US","secType":"STK","nameCN":"Zoetis Inc.","latestPrice":76.03,"timestamp":1785441600000,"preClose":77.93,"halted":0,"volume":4778594,"hourTrading":{"tag":"盘前","latestPrice":76.43,"preClose":76.03,"latestTime":"07:32 EDT","volume":3891,"amount":296620.38512999995,"timestamp":1785497550895,"change":0.4,"changeRate":0.005261,"amplitude":0.008286},"delay":0,"changeRate":-0.024380854613114403,"floatShares":419228118,"shares":419228118,"eps":6.106906,"marketStatus":"盘前交易","change":-1.9,"latestTime":"07-31 07:35:16 EDT","open":77,"high":77.38,"low":75.26,"amount":362797355.36784005,"amplitude":0.027204,"askPrice":77.75,"askSize":1,"bidPrice":76.03,"bidSize":9,"shortable":3,"etf":0,"ttmEps":6.106906,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1785504600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1359694800000,"exchange":"NYSE","adjPreClose":76.03,"dividendRate":0.0267,"preHourTrading":{"tag":"盘前","latestPrice":76.43,"preClose":76.03,"latestTime":"07:32 EDT","volume":3891,"amount":296620.38512999995,"timestamp":1785497550895,"change":0.4,"changeRate":0.005261,"amplitude":0.008286},"postHourTrading":{"tag":"盘后","latestPrice":76.2514,"preClose":76.03,"latestTime":"19:58 EDT","volume":155868,"amount":11852406.1289,"timestamp":1785455913479,"change":0.2214,"changeRate":0.002912,"amplitude":0.006696},"volumeRatio":0.900056091134891,"optionData":{"bulkOrders":[{"symbol":"ZTS","call":true,"expireDate":1787284800000,"strike":"85.0","timestamp":1785423873884,"price":1.35,"volume":1249,"amount":168615,"type":"+"}]},"impliedVol":0.5086,"impliedVolPercentile":0.94},"requestUrl":"/m/hq/s/ZTS","defaultTab":"news","newsList":[{"id":"1170879426","title":"“大空头”Burry继续押注科技股回调：增持英伟达PUT，继续做空半导体","url":"https://stock-news.laohu8.com/highlight/detail?id=1170879426","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170879426?lang=zh_cn&edition=full","pubTime":"2026-07-31 19:22","pubTimestamp":1785496939,"startTime":"0","endTime":"0","summary":"《大空头》原型人物Michael Burry并未收手，反而进一步加码做空英伟达、 美光等科技股。7月30日，Michael Burry再次大幅调整投资组合。这次没有减仓或清仓操作，而是全面提升风险敞口：一方面逢低买入 $DraftKings Inc.$、 $Zoetis Inc.$和 $lululemon athletica$；另一方面继续加码长期看跌布局，包括增持$纳指100ETF$和 $英伟达$的长期看跌期权，同时进一步做空 $美光科技$和 $半导体指数ETF-HOLDRs$。但在Burry看来，市场上的股票虽然成千上万，真正值得交易的机会却并不多。","market":"us","thumbnail":"https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRFHNkI6Ael5Jf9hWETLf-YXCJLk1-TP6uzpTkzAMF8ig&s=10","type":0,"news_type":0,"thumbnails":["https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRFHNkI6Ael5Jf9hWETLf-YXCJLk1-TP6uzpTkzAMF8ig&s=10"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVD","NVDU","NVDD","NVDL","LULU","MSFY","NVDS","NVDQ","07388","SMH","NVDA","FBL","MUYY","MUZ","ZTS","MUU","07788","ANV","MU","DRAY","NVDY","MSFD","NVDO","MSFL","MSFT","NVDB","QQQ","DKNX","NVDG","MSFW","DIPS","FBYY","NVII","DKNG","MSFX","NVYY","NVDX","METD","LULG","METU","MSFU","MSFO","MULL","DKUP","META","FBY","NVDW","METW","MIC","MUD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1188083297","title":"财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎","url":"https://stock-news.laohu8.com/highlight/detail?id=1188083297","media":"财报Agent","labels":["earningPreview"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188083297?lang=zh_cn&edition=full","pubTime":"2026-07-30 09:27","pubTimestamp":1785374831,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年08月06日美股盘前发布最新季度财报，市场关注营收与盈利修复节奏及费用投放对利润率的影响。市场一致预期本季度Zoetis Inc.营收为25.02亿美元，同比增3.87%，调整后每股收益为1.86美元，同比增14.74%；目前一致预期未覆盖本季度毛利率与净利率/净利润，相关数据暂未形成可比口径。上季度Zoetis Inc.营收22.62亿美元，同比增1.89%；毛利率71.71%；归属于母公司股东的净利润6.01亿美元，净利率26.57%；调整后每股收益1.53美元，同比增3.38%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增3.87%，机构观点偏谨慎","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653750538","title":"硕腾(ZTS)长效猫关节炎单抗药物Portela登陆欧盟与加拿大市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2653750538","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2653750538?lang=zh_cn&edition=full","pubTime":"2026-07-22 20:07","pubTimestamp":1784722053,"startTime":"0","endTime":"0","summary":"全球动物保健龙头硕腾宣布，长效单抗药物 Portela正式在加拿大与欧盟成员国上市。Portela 将与硕腾现有猫关节炎药物 Solensia 形成产品矩阵。同为抗 NGF 单抗，Solensia 需要每月注射，而 Portela 实现三月一针，大幅降低频繁送医、日常喂药难题，适配慢性骨关节炎长期管理需求。本次 Portela 在欧美市场商业化落地，进一步巩固其在宠物疼痛管理赛道的领先地位，满足老龄化宠物群体日益增长的慢病诊疗需求。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NjkwOTdhNzcyN2U0YmYwYmQ0MTU5ZmNlZDZlMGU5OTExMDg1MTQ4NjI3MDM=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302896","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774391.USD","EWC","LU0107464264.USD","LU2089284900.SGD","LU1721429741.USD","LU0158827948.USD","LU1236620750.USD","IE00B19Z9505.USD","LU0471298694.HKD","FSXEmain","LU2023251221.USD","BK4582","LU0385154629.USD","ZTS","BK4585","LU0079474960.USD","BK4007","LU2089283258.USD","LU1941712348.USD","LU2111349929.HKD","LU1059921491.USD","LU2360106947.USD","BK4534","FESXmain","LU0345774631.USD","LU2308191902.HKD","BK4588","LU1236620834.HKD","LU2028103732.USD","PAWZ","LU1721429402.USD","GB00BDT5M118.USD","LU1941712264.USD","LU0289739699.SGD","LU2271345857.HKD","LU0471298777.SGD","LU0158827781.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132505645","title":"澳大利亚ACCC裁定：Zoetis收购纽尔真检测需进入第二阶段审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1132505645","media":"投资观察","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132505645?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:30","pubTimestamp":1784284245,"startTime":"0","endTime":"0","summary":"澳大利亚竞争与消费者委员会于7月17日宣布，将对Zoetis Inc.收购纽尔真检测旗下基因组学业务的交易进行第二阶段审查。监管机构表示，目前尚未就相关问题达成最终结论，将在下一阶段继续深入评估此项收购案。ACCC在声明中特别指出，委员会正在审慎考量Zoetis通过此次交易获取澳大利亚境内更大量牛群遗传数据可能带来的竞争影响。根据ACCC的安排，针对此项收购的第二阶段审查通知已正式发布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1059921491.USD","LU2089283258.USD","LU1721429741.USD","LU1941712264.USD","PAWZ","LU2271345857.HKD","LU1721429402.USD","LU2360106947.USD","LU0345774391.USD","ZTS","IE00B19Z9505.USD","BK4588","LU0158827781.USD","BK4007","GB00BDT5M118.USD","LU0058720904.USD","LU2111349929.HKD","LU0289739699.SGD","NEOG","LU0385154629.USD","LU1236620750.USD","LU1236620834.HKD","LU2089284900.SGD","LU0471298777.SGD","LU0158827948.USD","LU2211817866.USD","BK4198","BK4585","LU0471298694.HKD","LU2028103732.USD","LU0079474960.USD","LU2308191902.HKD","LU1941712348.USD","LU2023251221.USD","LU0345774631.USD","BK4534","LU0107464264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104446115","title":"ACCC评估Zoetis获取澳洲牛群基因数据对市场竞争的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1104446115","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104446115?lang=zh_cn&edition=full","pubTime":"2026-07-17 14:16","pubTimestamp":1784268980,"startTime":"0","endTime":"0","summary":"澳大利亚竞争与消费者委员会（ACCC）正在评估一项交易可能带来的竞争影响。该交易涉及Zoetis Inc.获得澳大利亚境内更大量牛群遗传数据的访问权限。监管机构正审视此举是否会对市场公平竞争构成影响，尤其是在动物健康领域的数据获取方面。分析重点在于数据量的增加可能如何改变市场格局，以及这是否会赋予Zoetis相对于其他市场参与者潜在的不公平优势。这一审查反映了全球监管机构对数据密集型交易竞争效应的日益关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211817866.USD","LU2023251221.USD","LU1236620834.HKD","LU0107464264.USD","LU0289739699.SGD","LU1721429402.USD","LU2360106947.USD","GB00BDT5M118.USD","LU2308191902.HKD","BK4007","LU2089284900.SGD","LU2089283258.USD","LU0058720904.USD","LU0345774631.USD","BK4534","LU1941712348.USD","LU0385154629.USD","LU1059921491.USD","LU2028103732.USD","LU1941712264.USD","ZTS","NEOG","LU0079474960.USD","LU0158827781.USD","LU0471298694.HKD","BK4585","LU1236620750.USD","LU0345774391.USD","LU0158827948.USD","LU2111349929.HKD","IE00B19Z9505.USD","LU2271345857.HKD","LU0471298777.SGD","PAWZ","LU1721429741.USD","BK4588","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649982576","title":"硕腾(ZTS)家禽二联载体疫苗Poulvac® Procerta®HVT-ND获欧盟上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2649982576","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649982576?lang=zh_cn&edition=full","pubTime":"2026-07-07 19:41","pubTimestamp":1783424490,"startTime":"0","endTime":"0","summary":"产品管线层面，该款疫苗是硕腾 Procerta 系列第三款获欧盟认证的 HVT 载体疫苗，此前已有预防传染性法氏囊病 + 马立克氏病、三病联合防护两款产品上市。","market":"other","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302280","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620750.USD","LU0289739699.SGD","LU0058720904.USD","LU0345774631.USD","BK4007","159646","BK4178","LU1941712264.USD","LU0079474960.USD","PAWZ","LU0158827948.USD","LU0385154629.USD","LU1941712348.USD","LU0107464264.USD","LU1059921491.USD","LU1721429402.USD","GB00BDT5M118.USD","LU0471298694.HKD","LU2111349929.HKD","LU2271345857.HKD","BK4585","LU1721429741.USD","LU2089283258.USD","BK4588","LU0158827781.USD","LU2023251221.USD","HVT","LU1236620834.HKD","LU0345774391.USD","LU0471298777.SGD","LU2360106947.USD","IE00B19Z9505.USD","FESXmain","ZTS","FSXEmain","LU2308191902.HKD","LU2089284900.SGD","LU2028103732.USD","IPOS","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134049005","title":"异动解读｜硕腾盘中上涨5.07%，报81.575美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134049005","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134049005?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:57","pubTimestamp":1780585060,"startTime":"0","endTime":"0","summary":"6月4日，硕腾盘中上涨5.07%，报81.575美元/股，成交额1.69亿美元。硕腾所在的制药行业中，整体表现强势，个股中，诺和诺德涨5.33%，礼来涨5.13%，默沙东涨3.53%，强生涨1.91%，辉瑞涨1.81%。硕腾公司是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332288","title":"硕腾将出席两场投资者会议并参与炉边谈话","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332288","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637332288?lang=zh_cn&edition=full","pubTime":"2026-05-21 22:41","pubTimestamp":1779374464,"startTime":"0","endTime":"0","summary":"动物保健行业公司硕腾于当地时间5月20日宣布，公司代表将出席本月末及下月初的两场投资者会议，并进行炉边谈话。　　根据公司公告，硕腾将出席美东时间5月28日下午3时举行的Stifel 2026年Jaws & Paws会议，以及美东时间6月2日下午1时20分举行的William Blair第46届年度成长股会议。两场会议均设炉边谈话环节，投资者可通过硕腾官网投资者关系页面观看直播，回放也将在活动结束后提供。　　硕腾近期经营环境面临挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-21/doc-inhysnxi8161733.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["LU1941712348.USD","LU2360106947.USD","BK4585","LU0158827781.USD","BK4588","LU2271345857.HKD","BK4534","ZTS","LU1236620750.USD","LU0385154629.USD","LU1721429402.USD","LU1941712264.USD","LU2089284900.SGD","LU0289739699.SGD","LU0079474960.USD","LU0058720904.USD","LU2308191902.HKD","BK4007","LU2111349929.HKD","LU1236620834.HKD","LU0345774391.USD","GB00BDT5M118.USD","LU0471298694.HKD","LU0471298777.SGD","LU2023251221.USD","LU0107464264.USD","LU1059921491.USD","LU2028103732.USD","LU0158827948.USD","LU0345774631.USD","IE00B19Z9505.USD","LU2089283258.USD","LU1721429741.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110203987","title":"美国食品药品监督管理局授予Dectomax/Dectomax-CA1（多拉菌素注射液）紧急使用授权","url":"https://stock-news.laohu8.com/highlight/detail?id=1110203987","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110203987?lang=zh_cn&edition=full","pubTime":"2026-05-19 23:38","pubTimestamp":1779205101,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已正式授予Dectomax及Dectomax-CA1（多拉菌素注射液）这一可注射溶液的紧急使用授权（EUA）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1721429402.USD","LU2023251221.USD","LU0107464264.USD","ZTS","BK4585","LU1059921491.USD","LU1941712264.USD","GB00BDT5M118.USD","LU2360106947.USD","LU0158827781.USD","LU0345774391.USD","LU2028103732.USD","LU0289739699.SGD","LU1236620834.HKD","LU1236620750.USD","LU0058720904.USD","IE00B19Z9505.USD","LU0079474960.USD","LU0158827948.USD","LU0471298694.HKD","LU1721429741.USD","LU2308191902.HKD","BK4534","BK4007","LU1941712348.USD","LU0385154629.USD","BK4588","LU2271345857.HKD","LU0471298777.SGD","LU2089284900.SGD","LU2111349929.HKD","LU2089283258.USD","LU0345774631.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180452131","title":"异动解读 | Zoetis盘中大跌6.62%，业绩不及预期且下调全年指引引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1180452131","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180452131?lang=zh_cn&edition=full","pubTime":"2026-05-12 01:09","pubTimestamp":1778519348,"startTime":"0","endTime":"0","summary":"动物保健巨头Zoetis Inc.  今日盘中股价大幅下挫6.62%，延续了近期的弱势表现。消息面上，公司此前公布的第一季度业绩表现不佳，调整后每股收益为1.53美元，低于市场预期的1.61美元；营收为22.6亿美元，同样不及预期的23.1亿美元。公司管理层指出，宠物主对价格敏感度提高导致兽医就诊次数减少，美国市场收入因此下降8%，其中伴侣动物产品销售额下降11%。消费疲软对公司的核心业务形成了实质性冲击，持续压制了市场信心，引发了投资者的抛售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198917647","title":"异动解读 | Zoetis盘中大跌7.04%，业绩不及预期且下调全年指引引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1198917647","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198917647?lang=zh_cn&edition=full","pubTime":"2026-05-09 02:22","pubTimestamp":1778264552,"startTime":"0","endTime":"0","summary":"Zoetis Inc. (ZTS) 今日盘中大跌7.04%，延续了近期股价的弱势表现。消息面上，该公司此前公布的第一季度调整后每股收益为1.53美元，低于市场预期的1.62美元；营收为23亿美元，同比增长3%，但仍不及预期。同时，公司将全财年调整后每股收益指引下调至6.85-7.00美元，全年营收指引修订为96.8亿至99.6亿美元，指引中点均低于分析师预期。公司管理层指出，第一季度经营环境比预期更具挑战，宠物主价格敏感度提高导致兽医就诊减少，美国市场收入下降8%至11亿美元，其中伴侣动物产品销售额下降11%，反映出消费疲软对核心业务的实质性冲击，这引发了市场的持续担忧和抛售压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633173744","title":"硕腾成标普500今日最差成分股：财报“比看上去更糟”","url":"https://stock-news.laohu8.com/highlight/detail?id=2633173744","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633173744?lang=zh_cn&edition=full","pubTime":"2026-05-08 03:30","pubTimestamp":1778182200,"startTime":"0","endTime":"0","summary":"动物保健巨头硕腾周四股价暴跌逾20%，创下七年新低，成为标普500指数中表现最差的成分股。尽管财报数据已经令人失望，但多位分析师指出，实际情况比看上去更糟。　　其次，美国核心宠物业务严重恶化。美国业务营收下降8%至11亿美元，其中伴侣动物产品销售额更骤降11%，主要因宠物主价格敏感度提高、兽医就诊减少。该股年初至今已累计下跌约29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-08/doc-inhxckat7932903.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SPDN","ITOT","SVXY","MOAT","HIBL","ALLW","OEX","IVV","SPYM","IVE","ACWI","RSPU","VIXmain","MESmain","NOBL","VEU","VYLD","BK4581","BK4585","RSPN","IJR","SPUS","RSP","SSO","XDTE","SPXS","GPIX","VV","SPMO","SPHQ","JEPI","SPLV","SVOL","BK4534","SPUU","VTI","USMV","SPYI","TVIXF","GSLC","VTV","ZTS","DBSC","SH","BK4504","SPXU","OEF","VVIX","HIBS","IVW","SPYD","TSPY","SDS","BK4550","BK4588","SPHD","RSPA","SVIX","SPYV","UPRO","YSPY","BK4559","VXX","XYLD","IJH","SPGP","VBK","XLG","VIXM","SCHX","VIXY",".SPX","SCHB","BMAY","SPYG","SPYB","SFY","VXMmain","UVXY","SPXL","SPYU","ETFT","VXZ","SPYQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153119915","title":"异动解读 | Zoetis盘中暴跌21.89%，因一季度业绩不及预期且大幅下调全年盈利指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1153119915","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153119915?lang=zh_cn&edition=full","pubTime":"2026-05-08 00:03","pubTimestamp":1778169823,"startTime":"0","endTime":"0","summary":"动物保健巨头Zoetis Inc.今日盘中股价大跌21.89%，引发了市场的广泛关注。消息面上，公司同时公布了不及预期的第一季度财报并下调了全年业绩指引，双重利空打击了投资者信心。具体来看，公司第一季度调整后每股收益为1.53美元，低于市场预期的1.61美元；第一季度营收为22.6亿美元，亦不及分析师预期的23.1亿美元。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633129536","title":"美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633129536","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633129536?lang=zh_cn&edition=full","pubTime":"2026-05-07 23:00","pubTimestamp":1778166008,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周四，Zoetis(ZTS.US)早盘暴跌超20%，创阶段新低，现报88.05美元。消息面上，5月7日，该公司公布的第一季度调整后每股收益为1.53美元，低于市场预期的1.62美元;营收为23亿美元，增长3%，但低于部分市场预期。该公司将2026财年调整后每股收益指引下调至6.85-7.00美元，并将全年营收指引修订为96.8亿至99.6亿美元，其指引中点均低于分析师预期。公司首席执行官表示，第一季度经营环境比预期更具挑战，宠物主价格敏感度提高导致兽医就诊减少，美国市场收入因此下降8%至11亿美元，其中伴侣动物产品销售额下降11%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"美股异动 | 下调2026财年业绩指引 Zoetis(ZTS.US)早盘暴跌超20%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1721429741.USD","LU0079474960.USD","IE00B19Z9505.USD","LU0345774631.USD","LU2271345857.HKD","LU0058720904.USD","LU1941712264.USD","LU0289739699.SGD","LU0471298777.SGD","LU1236620750.USD","ZTS","LU0471298694.HKD","LU1941712348.USD","LU0345774391.USD","LU0107464264.USD","LU2089284900.SGD","GB00BDT5M118.USD","BK4007","LU2089283258.USD","LU2308191902.HKD","LU1059921491.USD","BK4585","BK4534","LU2028103732.USD","LU0158827948.USD","LU2360106947.USD","LU1236620834.HKD","LU1721429402.USD","BK4588","LU2023251221.USD","LU0385154629.USD","LU2111349929.HKD","LU0158827781.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159016493","title":"异动解读 | Zoetis盘前大跌8.74%，因下调全年业绩预期且第一季度业绩未达预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1159016493","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159016493?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:29","pubTimestamp":1778153385,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc.（ZTS）今日盘前股价大跌8.74%，引发了市场关注。消息面上，公司同时宣布下调全年业绩预期，并将第一季度业绩未达分析师预期的消息公之于众。具体而言，公司将全年每股盈利预期从原先的7.00-7.10美元下调至6.85-7.00美元。此外，公司报告的第一季度调整后每股收益为1.53美元，低于分析师预期的1.61美元；第一季度营收为22.6亿美元，也低于分析师预期的23.1亿美元。业绩预期的下调和实际业绩的疲软，直接影响了投资者对公司短期盈利能力和增长前景的信心，从而导致股价在盘前交易时段承压大幅下跌。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123843324","title":"财报前瞻｜Zoetis Inc.本季度营收预计增5.26%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1123843324","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123843324?lang=zh_cn&edition=full","pubTime":"2026-04-30 08:47","pubTimestamp":1777510038,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年05月07日盘前发布财报，市场关注营收与每股收益的同比增长以及核心产品线的延续性表现。市场一致预期本季度Zoetis Inc.营收为23.05亿美元，同比增长5.26%；调整后每股收益为1.62美元，同比增长15.90%；息税前利润为9.18亿美元，同比增长9.44%；目前未有对本季度毛利率与净利率的明确一致预测，故不予展示。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增5.26%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162582301","title":"硕腾公司收购Neogen®动物基因组学业务，加速精准动物健康创新","url":"https://stock-news.laohu8.com/highlight/detail?id=1162582301","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162582301?lang=zh_cn&edition=full","pubTime":"2026-03-02 20:11","pubTimestamp":1772453469,"startTime":"0","endTime":"0","summary":"硕腾公司宣布将收购Neogen®的动物基因组学业务，此举将显著推动其在精准动物健康领域的创新进程。此次收购标志着硕腾在动物保健解决方案方面的战略布局进一步深化，旨在通过基因组学技术提升动物健康管理的精确性和效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1941712264.USD","LU0079474960.USD","BK4198","LU0471298777.SGD","LU1941712348.USD","LU0158827781.USD","LU2089284900.SGD","LU2271345857.HKD","LU0471298694.HKD","LU2211817866.USD","LU1721429741.USD","BK4585","LU1721429402.USD","ZTS","NEOG","LU0385154629.USD","BK4534","LU2308191902.HKD","LU2023251221.USD","LU0289739699.SGD","LU1236620750.USD","LU0345774631.USD","LU0107464264.USD","BK4588","LU0345774391.USD","BK4007","LU2089283258.USD","LU2111349929.HKD","LU1236620834.HKD","LU2360106947.USD","LU2028103732.USD","LU0058720904.USD","LU0158827948.USD","IE00B19Z9505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133797891","title":"异动解读 | Zoetis季度业绩及展望超预期，盘前大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133797891","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133797891?lang=zh_cn&edition=full","pubTime":"2026-02-12 20:37","pubTimestamp":1770899834,"startTime":"0","endTime":"0","summary":"动物保健公司Zoetis Inc. (ZTS) 今日盘前股价大幅上涨6.12%，表现强劲。消息面上，该公司公布的第四季度业绩及2026年财务指引均超出市场预期。具体来看，Zoetis第四季度调整后每股利润为1.48美元，高于市场预期的1.40美元。同时，公司预计2026年调整后每股收益将在7.00美元至7.10美元之间，其中间值高于分析师普遍预期的6.80美元；预计2026年营收将在98.25亿美元至100.25亿美元之间，其中间值也高于市场预期的99.14亿美元。这些乐观的业绩数据和未来展望显著提振了投资者信心，成为推动股价在盘前交易时段大幅走高的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124112870","title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1124112870","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124112870?lang=zh_cn&edition=full","pubTime":"2026-02-05 10:14","pubTimestamp":1770257650,"startTime":"0","endTime":"0","summary":"Zoetis Inc.将于2026年02月12日发布最新季度财报，市场预期其营收与每股收益将温和增长，盈利质量与费用节奏成为关注焦点。从近期机构研报与观点追踪看，市场对Zoetis Inc.的看法偏多，占比较高的一方认为本季度将延续稳健增长轨迹。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜Zoetis Inc.本季度营收预计增2.61%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512046953","title":"硕腾2024财年实现净利润24.86亿美元，同比增加6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512046953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512046953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721669,"startTime":"0","endTime":"0","summary":"2月17日，硕腾公布财报，公告显示公司2024财年净利润为24.86亿美元，同比增加6.06%；其中营业收入为92.56亿美元，同比增加8.33%，每股基本收益为5.47美元。从资产负债表来看，硕腾总负债94.67亿美元，其中短期债务14.01亿美元，资产负债比为1.51，流动比率为1.76。机构评级：截至2025年2月17日，当前有15家机构对硕腾目标价做出预测，其中目标均价为214.47美元，其中最低目标价为180.00美元，最高目标价为244.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000128a2481c28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ZTS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zoetis.com","stockEarnings":[{"period":"1week","weight":0.0196},{"period":"1month","weight":0.058},{"period":"3month","weight":-0.334},{"period":"6month","weight":-0.3909},{"period":"1year","weight":-0.4891},{"period":"ytd","weight":-0.3957}],"compareEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.169},{"period":"ytd","weight":0.0876}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"硕腾公司于2012年7月在美国特拉华州成立。硕腾是动物保健行业的全球领先企业，专注于药物、疫苗、诊断产品和服务、生物设备、基因测试和精准动物健康的发现、开发、制造和商业化。","yearOnYearQuotes":[{"month":1,"riseRate":0.461538,"avgChangeRate":-0.014971},{"month":2,"riseRate":0.615385,"avgChangeRate":0.01803},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.019618},{"month":4,"riseRate":0.5,"avgChangeRate":0.012455},{"month":5,"riseRate":0.642857,"avgChangeRate":0.001908},{"month":6,"riseRate":0.642857,"avgChangeRate":0.007202},{"month":7,"riseRate":0.857143,"avgChangeRate":0.033852},{"month":8,"riseRate":0.769231,"avgChangeRate":0.012395},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.007561},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.008448},{"month":11,"riseRate":0.692308,"avgChangeRate":0.038835},{"month":12,"riseRate":0.538462,"avgChangeRate":0.016303}],"exchange":"NYSE","name":"Zoetis Inc.","nameEN":"Zoetis"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Zoetis Inc.,ZTS,Zoetis Inc.股票,Zoetis Inc.股票老虎,Zoetis Inc.股票老虎国际,Zoetis Inc.行情,Zoetis Inc.股票行情,Zoetis Inc.股价,Zoetis Inc.股市,Zoetis Inc.股票价格,Zoetis Inc.股票交易,Zoetis Inc.股票购买,Zoetis Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zoetis Inc.(ZTS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Zoetis Inc.(ZTS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}